How I treat patients with MRD after transplantation

During the 7th World Congress on Controversies in Multiple Myeloma (COMy), the Multiple Myeloma Hub spoke with Michele Cavo, University of Bologna, Bologna, IT. He discusses how to treat patients with minimal residual disease (MRD) after transplantation.

Cavo firstly discusses the prognostic importance of MRD prior to maintenance therapy. He then outlines treatment options for patients who are MRD positive following autologous hematopoietic stem cell transplantation. Next, he details when to discontinue maintenance therapy, and emphasizes the need for sustained MRD negativity. He finishes on where and how to assess MRD.